EBITDA Growth
-5.44%
TTM · Period ending:
CVS EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-5.44%period ending
Latest reported-5.44%period ending
CVS TTM EBITDA YoY % (8.50% → -5.44%)
Year-over-year change
High-resolution chart · PNG
CVS ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 11.9552% | |
| 14.648% | |
| 14.5677% | |
| 17.6225% | |
| 15.626% | |
| 17.7672% | |
| 19.7594% | |
| 20.7148% | |
| 20.3249% | |
| 30.4275% | |
| 32.1909% | |
| 39.7408% | |
| 68.1515% | |
| 36.2502% | |
| 73.6627% | |
| 50.8063% | |
| 20.295% | |
| 51.0837% | |
| 21.6805% | |
| -25.3822% | |
| -31.3773% | |
| -41.0427% | |
| -48.3686% | |
| -14.011% | |
| -2.4497% | |
| -8.4357% | |
| 0.4296% | |
| 53.4653% | |
| 44.4224% | |
| 54.9212% | |
| 44.9564% | |
| -36.7033% | |
| -33.8981% | |
| -30.6735% | |
| -30.4418% | |
| 11.0717% | |
| 10.1604% | |
| 2.4064% | |
| 3.8289% | |
| -1.0655% | |
| -1.5146% | |
| 5.6129% | |
| 2.5834% | |
| 121.6593% | |
| 137.1805% | |
| 199.6614% | |
| 28.6805% | |
| -423.9606% | |
| -340.1688% | |
| -187.4867% | |
| 12.605% | |
| 26.5344% | |
| 17.9253% | |
| 59.437% | |
| 8.3161% | |
| 8.9629% | |
| 8.5047% |